Q32 Bio


Q32 Bio is a biotechnology company developing therapies targeting powerful regulators of the innate and adaptive immune systems, with the goal of re-balancing the immune system in severe autoimmune and inflammatory diseases.

Industries

Employees

11-50

Links


Org chart

Jodie Morrison
CEO And Board Member
Collapse
Shelia Violette
Co-Founder & Chief Scientific Officer
David Appugliese
SVP & Head of People
Maria Marzilli
EVP, Corporate Strategy & Program Operations
Hong Wu, MD, PhD, DABT
Senior Vice President, Head Of Development At Q32 Bio
Lee Kalowski
President & Chief Financial Officer
Saul W. Fink
Chief Technical Officer
Adrien Sipos
Interim Chief Medical Officer

Board & advisors

Mark Iwicki
Director
Isaac Manke
Director
Diyong Xu
Director
Mary Thistle
Director
John P. Atkinson
Scientific Advisor
Michael Holers
Scientific Advisor
Brian Kotzin
Scientific Advisor